NM_000051.4:c.94C>T
Variant summary
Our verdict is Likely benign. Variant got -3 ACMG points: 0P and 3B. BP4_ModerateBP6
The NM_000051.4(ATM):c.94C>T(p.Arg32Cys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000533 in 1,613,490 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_000051.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -3 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ATM | NM_000051.4 | c.94C>T | p.Arg32Cys | missense_variant | Exon 3 of 63 | ENST00000675843.1 | NP_000042.3 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000197 AC: 3AN: 152080Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000876 AC: 22AN: 251158Hom.: 0 AF XY: 0.000103 AC XY: 14AN XY: 135830
GnomAD4 exome AF: 0.0000568 AC: 83AN: 1461410Hom.: 0 Cov.: 32 AF XY: 0.0000770 AC XY: 56AN XY: 727008
GnomAD4 genome AF: 0.0000197 AC: 3AN: 152080Hom.: 0 Cov.: 33 AF XY: 0.0000135 AC XY: 1AN XY: 74312
ClinVar
Submissions by phenotype
not specified Uncertain:1Benign:1
Classification criteria: BS1, BP4 -
Variant summary: ATM c.94C>T (p.Arg32Cys) results in a non-conservative amino acid change located in the Telomere-length maintenance and DNA damage (IPR021668) of the encoded protein sequence. Four of five in-silico tools predict a damaging effect of the variant on protein function. The variant allele was found at a frequency of 8.8e-05 in 251158 control chromosomes. This frequency is not significantly higher than estimated for a pathogenic variant in ATM causing Ataxia-Telangiectasia (8.8e-05 vs 0.004), allowing no conclusion about variant significance. c.94C>T has been reported in the literature in at-least one individual affected with Colorectal cancer, without strong evidence for causality (deOliveira-Garcia_2022). In a large study evaluating breast cancer cases and controls in the Breast Cancer Association Consortium (BCAC), the variant was reported in 6/53461 controls and 2/60466 case (Dorling_2021 through LOVD). In another case-control studies of Biliary tract cancer, this variant was not found in 1,229 cases but was reported at 0.001% in 37,583 controls (Okawa_2023). These report(s) do not provide unequivocal conclusions about association of the variant with Ataxia-Telangiectasia or other ATM-related diseases. To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. The following publications have been ascertained in the context of this evaluation (PMID: 33471991, 36243179, 35534704). ClinVar contains an entry for this variant (Variation ID: 142913, Likely benign, n=3; VUS, n=5). Based on the evidence outlined above, the variant was classified as uncertain significance. -
Ataxia-telangiectasia syndrome Uncertain:1Benign:1
- -
- -
Hereditary cancer-predisposing syndrome Benign:2
This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -
- -
not provided Uncertain:1
In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; Published functional studies demonstrate activity similar to wild type in DNA damage and cell cycle checkpoint assays (PMID: 29423082); This variant is associated with the following publications: (PMID: 24416720, 36200007, 33471991, 36243179, 30287823, 29423082, 35534704) -
Malignant tumor of breast Uncertain:1
The ATM p.Arg32Cys variant was identified in 1 of 400 proband chromosomes (frequency: 0.003) from American Indian and non-American Indian cancer individuals undergoing radiation therapy (Petereit 2013). The variant was also identified in dbSNP (ID: rs148061139) “With Uncertain significance” allele, ClinVar (classified as uncertain significance by Ambry Genetics, Invitae and GeneDx), Clinvitae (3X as uncertain significance) and Cosmic (1X in an adenocarcinoma of the large intestine). The variant was not identified in GeneInsight-COGR, MutDB, LOVD 3.0, and ATM-LOVD databases. The variant was identified in control databases in 24 of 277068 chromosomes at a frequency of 0.00009 in the following populations: South Asian in 17 of 16510 chromosomes (freq. 0.00055), East Asian in 2 of 8654 chromosomes (freq. 0.0002), and European (Non-Finnish) in 2 of 66696 chromosomes (freq. 0.00003) increasing the likelihood this could be a low frequency variant (Genome Aggregation Consortium Feb 27, 2017). Although the p.Arg32 residue is not conserved in mammals and other organisms, computational analyses (PolyPhen-2, SIFT, AlignGVGD, BLOSUM, MutationTaster) suggest that the Cys variant may impact the protein. The variant occurs outside of the splicing consensus sequence and 1 of 5 in silico or computational prediction software programs (SpliceSiteFinder, MaxEntScan, NNSPLICE, GeneSplicer, HumanSpliceFinder) predict a greater than 10% difference in splicing; this is not very predictive of pathogenicity. In summary, based on the above information the clinical significance of this variant cannot be determined with certainty at this time. This variant is classified as a variant of uncertain significance. -
Familial cancer of breast Uncertain:1
This variant was classified as: Uncertain significance. The available evidence on this variant's pathogenicity is insufficient or conflicting. The following ACMG criteria were applied in classifying this variant: PP3,BP1. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at